These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38543207)

  • 21. Comparison of dissolution profiles for albendazole tablets using USP apparatus 2 and 4.
    Hurtado y de la Peña M; Vargas Alvarado Y; Domínguez-Ramírez AM; Cortés Arroyo AR
    Drug Dev Ind Pharm; 2003 Aug; 29(7):777-84. PubMed ID: 12906335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug release from semisolid dosage forms: a comparison of two testing methods.
    Petró É; Paál TL; Erős I; Kenneth AS; Baki G; Csóka I
    Pharm Dev Technol; 2015 May; 20(3):330-6. PubMed ID: 24328512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro-In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action.
    Rath S; Kanfer I
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations.
    Fotaki N; Aivaliotis A; Butler J; Dressman J; Fischbach M; Hempenstall J; Klein S; Reppas C
    Eur J Pharm Biopharm; 2009 Sep; 73(1):115-20. PubMed ID: 19442728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical Quality by Design, Life Cycle Management, and Method Control.
    Verch T; Campa C; Chéry CC; Frenkel R; Graul T; Jaya N; Nakhle B; Springall J; Starkey J; Wypych J; Ranheim T
    AAPS J; 2022 Feb; 24(1):34. PubMed ID: 35149913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel USP apparatus 4 based release testing method for dispersed systems.
    Bhardwaj U; Burgess DJ
    Int J Pharm; 2010 Mar; 388(1-2):287-94. PubMed ID: 20083176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro release test (IVRT): Principles and applications.
    Shah VP; Simona Miron D; Ștefan Rădulescu F; Cardot JM; Maibach HI
    Int J Pharm; 2022 Oct; 626():122159. PubMed ID: 36067919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
    Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
    Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
    Bao Q; Burgess DJ
    Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the utility of an in vitro release test for optimizing semisolid dosage forms.
    Proniuk S; Dixon SE; Blanchard J
    Pharm Dev Technol; 2001 Aug; 6(3):469-76. PubMed ID: 11485188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are European marketed acyclovir 5% cream products similar? Comparison with EU and US reference product.
    Miron DS; Rădulescu FȘ; Voicu VA; Mînea A; Cardot JM; Shah VP
    Drug Dev Ind Pharm; 2021 Jun; 47(6):990-1000. PubMed ID: 34279163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro release testing method development for long-acting injectable suspensions.
    Bao Q; Wang X; Zou Y; Wang Y; Burgess DJ
    Int J Pharm; 2022 Jun; 622():121840. PubMed ID: 35595043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of USP antibody standard for system suitability in capillary electrophoresis sodium dodecyl sulfate (CE-SDS) for release and stability methods.
    Esterman AL; Katiyar A; Krishnamurthy G
    J Pharm Biomed Anal; 2016 Sep; 128():447-454. PubMed ID: 27344634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms.
    Hauck WW; Shah VP; Shaw SW; Ueda CT
    Pharm Res; 2007 Nov; 24(11):2018-24. PubMed ID: 17530388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of additives on release and in vitro skin retention of flavonoids from emulsion and gel semisolid formulations.
    Dyja R; Jankowski A
    Int J Cosmet Sci; 2017 Aug; 39(4):442-449. PubMed ID: 28267214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development in release testing of topical dosage forms: use of the Enhancer Cell with automated sampling.
    Rege PR; Vilivalam VD; Collins CC
    J Pharm Biomed Anal; 1998 Sep; 17(8):1226-33. PubMed ID: 9800641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.
    Andreas CJ; Chen YC; Markopoulos C; Reppas C; Dressman J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):39-50. PubMed ID: 26391972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drilling down the bioequivalence assessment of topical antifungal products: Microstructure and release.
    Miranda M; Cardoso C; Pais AACC; Brown M; Vitorino C
    Eur J Pharm Biopharm; 2023 Apr; 185():94-106. PubMed ID: 36806630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical method development, validation, and out-of-specification investigations for polyethylene glycol.
    Huang TC; Chu G; Singh S
    J Pharm Biomed Anal; 2023 Oct; 235():115613. PubMed ID: 37544274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Quality Control Study of Different Brands of Diclofenac Sodium Tablet Available in Local and Government Pharmacies by In-Vitro Testing.
    Gupta MM; Khoorban A; Ali A; Ramlogan O; Talukdar D
    Cureus; 2020 Nov; 12(11):e11348. PubMed ID: 33304683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.